Atlas Arteria (ASX:ALX) ROCE %: 4.18% (As of Dec. 2025)


ASX:ALX Atlas Arteria Ltd ASX:ALX
75 GF Score
Price A$5.10
GF Value A$5.86
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Atlas Arteria ROCE %?

Atlas Arteria ASX:ALX 75 ROCE % is 4.18% as of Dec. 2025. GuruFocus rates ASX:ALX with a GF Score™ of 75/100 and a GF Value™ of A$5.86 (Modestly Undervalued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Atlas Arteria's annualized ROCE % for the quarter that ended in Dec. 2025 was 4.18%.

Atlas Arteria  (ASX:ALX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Atlas Arteria ROCE % Related Terms

Atlas Arteria ROCE % Historical Data

* Premium members only.

The historical data trend for Atlas Arteria's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atlas Arteria ROCE % Chart

Atlas Arteria Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.06 5.04 4.42 4.65 3.67

Atlas Arteria Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.26 4.20 5.25 3.18 4.18
ASX:ALX
75GF Score
Atlas Arteria Ltd ASX:ALX
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Atlas Arteria ROCE % Calculation

Atlas Arteria's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=287.4/( ( (8262 - 134.3) + (7655.8 - 132.7) )/ 2 )
=287.4/( (8127.7+7523.1)/ 2 )
=287.4/7825.4
=3.67 %

Atlas Arteria's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=321.2/( ( (7957.4 - 128.4) + (7655.8 - 132.7) )/ 2 )
=321.2/( ( 7829 + 7523.1 )/ 2 )
=321.2/7676.05
=4.18 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 4.18% mean?
Atlas Arteria (ASX:ALX) has a ROCE % of 4.18% as of Dec. 2025.
Is Atlas Arteria's ROCE % too high?
Atlas Arteria's current ROCE % is 4.18%. The Construction industry median ROCE % is 8.25. Atlas Arteria's value of 4.18% is 49.3% below this industry median. Overall, Atlas Arteria has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Atlas Arteria's ROCE % compare to competitors?
Atlas Arteria's ROCE % of 4.18% can be compared against companies in the Construction industry. The industry median ROCE % is 8.25. Atlas Arteria's value of 4.18% is 49.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Construction company?
The median ROCE % among Construction companies is 8.25, based on 1,754 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Atlas Arteria's current ROCE % of 4.18% is 49.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Construction industry, the median ROCE % is 8.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Atlas Arteria's current ROCE % is 4.18%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atlas Arteria stock overvalued right now?
Based on GuruFocus' analysis, Atlas Arteria (ASX:ALX) is currently considered Modestly Undervalued. The stock's GF Value™ is A$5.86, compared to a current price of A$5.10 — trading 13% below its estimated fair value. The current ROCE % is 4.18% and 49.3% below the Construction industry median of 8.25. Atlas Arteria's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Atlas Arteria (ASX:ALX), the current ROCE % is 4.18% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Atlas Arteria (ASX:ALX) Overvalued in 2026?

Based on GuruFocus' analysis, Atlas Arteria stock appears to be undervalued. The current stock price of A$5.10 is trading 13% below its estimated GF Value™ of A$5.86. GuruFocus considers Atlas Arteria to be Modestly Undervalued.

Key valuation signals for ASX:ALX:

  • ROCE %: 4.18%
  • GF Value™: A$5.86 vs. price of A$5.10 (13% below fair value)
  • GF Score™: 75/100 with 6 warning signs
  • Industry Position: 49.3% below the Construction median

No single metric tells the full story. See the ASX:ALX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Atlas Arteria Business Description

Other Exchanges MAQAF:USAM82:Germany
Address 180 Flinders Street, Level 1, Melbourne, VIC, AUS, 3000
Atlas Arteria is a global toll-road investor created out of the reorganization of Macquarie Infrastructure Group in 2010. The firm's main asset is a 30.82% stake in APRR. APRR owns concessions to toll more than 2,300 kilometers of motorways in eastern France, most ending by late 2035. The firm also wholly owns the Dulles Greenway and 66.67% of the Chicago Skyway, both in the US.
75GF Score

Get the complete analysis for ASX:ALX

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$5.10
Price
A$5.86
GF Value